Myeloid sirtuin 6 deficiency accelerates experimental rheumatoid arthritis by enhancing macrophage activation and infiltration into synovium
暂无分享,去创建一个
Hyun Min Jeon | S. M. Yi | Byung-Hyun Park | E. Bae | H. Noh | Y. Cheon | Sang-Il Lee | N. Y. Lee | S. J. Woo | H. M. Jeon
[1] Byung-Hyun Park,et al. Deacetylation of XBP1s by sirtuin 6 confers resistance to ER stress-induced hepatic steatosis , 2019, Experimental & Molecular Medicine.
[2] Mi-kyung Kim,et al. Adipose sirtuin 6 drives macrophage polarization toward M2 through IL-4 production and maintains systemic insulin sensitivity in mice and humans , 2019, Experimental & Molecular Medicine.
[3] Byung-Hyun Park,et al. Myeloid cell-specific sirtuin 6 deficiency delays wound healing in mice by modulating inflammation and macrophage phenotypes , 2019, Experimental & Molecular Medicine.
[4] J. Zhen,et al. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling , 2017, Nature Communications.
[5] Mi-kyung Kim,et al. Myeloid Sirtuin 6 Deficiency Causes Insulin Resistance in High-Fat Diet–Fed Mice by Eliciting Macrophage Polarization Toward an M1 Phenotype , 2017, Diabetes.
[6] Byung-Hyun Park,et al. Hepatocyte‐specific sirtuin 6 deletion predisposes to nonalcoholic steatohepatitis by up‐regulation of Bach1, an Nrf2 repressor , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] C. Shun,et al. Sirtuin 6 suppresses hypoxia‐induced inflammatory response in human osteoblasts via inhibition of reactive oxygen species production and glycolysis—A therapeutic implication in inflammatory bone resorption , 2017, BioFactors.
[8] Guoheng Xu,et al. Fat-Specific Sirt6 Ablation Sensitizes Mice to High-Fat Diet–Induced Obesity and Insulin Resistance by Inhibiting Lipolysis , 2017, Diabetes.
[9] A. Mantovani,et al. Macrophage heterogeneity in the context of rheumatoid arthritis , 2016, Nature Reviews Rheumatology.
[10] Byung-Hyun Park,et al. Insulin secretion impairment in Sirt6 knockout pancreatic β cells is mediated by suppression of the FoxO1-Pdx1-Glut2 pathway , 2016, Scientific Reports.
[11] Byung-Hyun Park,et al. Overexpression of sirtuin 6 suppresses allergic airway inflammation through deacetylation of GATA3. , 2016, The Journal of allergy and clinical immunology.
[12] Sanjeev Das,et al. SIRT6 deacetylates PKM2 to suppress its nuclear localization and oncogenic functions , 2016, Proceedings of the National Academy of Sciences.
[13] Fangcai Li,et al. Overexpression of Sirtuin 6 suppresses cellular senescence and NF-κB mediated inflammatory responses in osteoarthritis development , 2015, Scientific Reports.
[14] K. Jang,et al. Myeloid deletion of SIRT1 suppresses collagen-induced arthritis in mice by modulating dendritic cell maturation , 2016, Experimental & Molecular Medicine.
[15] G. Haines,et al. Nonclassical Ly6C(-) monocytes drive the development of inflammatory arthritis in mice. , 2014, Cell reports.
[16] C. Deng,et al. Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion , 2014, Proceedings of the National Academy of Sciences.
[17] R. Gay,et al. SIRT6 regulates the cigarette smoke-induced signalling in rheumatoid arthritis synovial fibroblasts , 2014, Journal of Molecular Medicine.
[18] Byung-Hyun Park,et al. Myeloid Deletion of SIRT1 Aggravates Serum Transfer Arthritis in Mice via Nuclear Factor-κB Activation , 2014, PloS one.
[19] Jin-woo Park,et al. Overexpression of sirtuin 6 suppresses inflammatory responses and bone destruction in mice with collagen-induced arthritis. , 2013, Arthritis and rheumatism.
[20] M. Hsiao,et al. Simvastatin inhibits cysteine-rich protein 61 expression in rheumatoid arthritis synovial fibroblasts through the regulation of sirtuin-1/FoxO3a signaling. , 2013, Arthritis and rheumatism.
[21] P. Puigserver,et al. The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis. , 2012, Molecular cell.
[22] Lixia Gan,et al. FOXO1 increases CCL20 to promote NF-κB-dependent lymphocyte chemotaxis. , 2012, Molecular endocrinology.
[23] C. Glass,et al. FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages , 2010, The EMBO journal.
[24] A. Silman,et al. UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha, , 2010 .
[25] A. Silman,et al. Rheumatoid arthritis classifi cation criteria : an American College of Rheumatology / European League Against Rheumatism collaborative initiative , 2010 .
[26] H. Perlman,et al. Innate immunity and rheumatoid arthritis. , 2010, Rheumatic diseases clinics of North America.
[27] P. V. van Riel,et al. The Disease Activity Score and the EULAR response criteria , 2009 .
[28] Yi Lu,et al. FoxO1 Links Insulin Resistance to Proinflammatory Cytokine IL-1β Production in Macrophages , 2009, Diabetes.
[29] B. Bresnihan,et al. Synovial Tissue Sublining CD68 Expression Is a Biomarker of Therapeutic Response in Rheumatoid Arthritis Clinical Trials: Consistency Across Centers , 2009, The Journal of Rheumatology.
[30] Howard Y. Chang,et al. SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-κB-Dependent Gene Expression and Organismal Life Span , 2009, Cell.
[31] G. Burmester,et al. Cells of the synovium in rheumatoid arthritis. Macrophages , 2007, Arthritis research & therapy.
[32] Oliver Distler,et al. Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts , 2007, Arthritis Research & Therapy.
[33] P. Tak,et al. Inhibition of forkhead box class O family member transcription factors in rheumatoid synovial tissue. , 2007, Arthritis and rheumatism.
[34] Thomas Pap,et al. Mechanisms of Disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis , 2005, Nature Clinical Practice Rheumatology.
[35] A. Zwinderman,et al. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis , 2004, Annals of the rheumatic diseases.
[36] G. Haines,et al. RANTES expression and contribution to monocyte chemotaxis in arthritis. , 1998, Clinical immunology and immunopathology.
[37] B. Bresnihan,et al. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. , 1994, Annals of the rheumatic diseases.
[38] S. McColl,et al. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. , 1993, The Journal of biological chemistry.
[39] B. Bresnihan,et al. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. , 1996, Arthritis and rheumatism.